BVR Candidate Highlights

We are thrilled to present an exceptional candidate who epitomizes excellence in biochemistry and molecular biology. With extensive expertise in siRNA, mRNA, CRISPR gene editing, and cell therapies, this accomplished professional has demonstrated remarkable success across startups and global pharmaceutical corporations.

Key Accomplishments:

● Translational Leadership: Successfully transitioned RNA and DNA-based drugs from research to early development and cGMP processes, spearheading innovative oligonucleotide and gene delivery platforms.

● Innovative Problem-Solving: Proactively addressed potential side effects of emerging therapeutic approaches, such as immuno-safety, off-target gene editing, and pharmacokinetics protocols.

● Technological Advancements: Directed discovery teams to develop lentiviral vector platforms and next-generation sequencing protocols, significantly enhancing research efficiency.

● Strategic Impact: Led advancements in mRNA therapeutics beyond vaccines, driving pivotal partnerships and breakthrough technology applications.

● CRISPR Expertise: Played a key role in cross-functional initiatives for CRISPR gene editing, achieving successful IND filings and contributing to a $175M licensing deal.

This candidate thrives in dynamic, innovative environments that prioritize collaboration, scientific rigor, and impactful leadership. With a stellar publication record and fluency in German, French, and English, they bring a global perspective and unparalleled expertise to their work.

If you are seeking a transformative leader to drive your team’s success, we would be delighted to discuss how this individual can contribute to your organization. Let us know a convenient time to connect!

 An experienced scientific leader specializing in high-throughput screening and automation is seeking a new challenge in the Northeast. 

With a strong background in interdisciplinary project leadership, this professional has successfully worked in small molecule synthesis and optimization to high-throughput screening, leveraging automation to enhance research efficiency. Their expertise includes automating complex processes, such as biological sample preparation for gene expression profiling and sequencing and developing innovative research tools for precision medicine applications.

With a diverse research background spanning oncology, stem cells, and neurodegenerative diseases, they have played a key role in collaborations with pharmaceutical companies, overseeing joint research committees and leading external projects. As a project manager, they have managed budgeting, timeline forecasting, and operational planning, contributing to the development of business strategies and participating in business development outreach.

Their technical expertise includes: 

• Designing and implementing robotic platforms 
• Authoring standard operating procedures (SOPs) for automation.
• Handling data management software and cheminformatics. 

They have also served as a Principal Investigator on SBIR grant applications and played a key role in implementing company-wide electronic notebook systems to streamline research documentation and data integrity.

Please reach out if you think this excellent candidate would be an asset to your team.

An innovative scientist in the Greater Boston Area is ready to take on complex biological challenges. Passionate about leveraging models that closely mirror human disease, this candidate is dedicated to accelerating therapeutic discoveries.

As a Director and Subject Matter Expert (SME) in small molecules, biologics, and genetic medicines, they have successfully led stem cell and functional genomics teams across multiple organizations, driving disease discovery and drug mechanism elucidation.

Expertise & Specialties:

• Technical Skills: Cell biology induced pluripotent stem cells (iPSCs) in 2D & 3D cultures, functional genomics (bulk & single-cell sequencing, epigenetic profiling), spatial transcriptomics, protein biochemistry, and biophysical assays.
• Leadership & Collaboration: Led functional (cell biology & functional genomics) and project teams, cross-functional collaborations, and project management initiatives.
• Disease Focus: Primarily Central Nervous System (CNS) disorders, including neurodevelopmental diseases (e.g., autism) and neurodegenerative diseases (e.g., ALS, MS), as well as immuno-oncology and CAR-T therapies. Also supported early discovery efforts in ophthalmology, liver diseases, and peripheral neuron diseases.
• Drug Development Stage: Preclinical and discovery-stage research.

Seeking leadership opportunities in preclinical/discovery research, platform development, or translational biology (in vitro and in vivo). This candidate brings the expertise and strategic vision needed to drive innovation in therapeutic development.

An Early-Stage Researcher with a 2024 Ph.D. in Neuroscience is seeking the next step in their growing career.  

Specializing in nanoengineering and drug delivery, this professional has experience in the design, development, and preclinical testing of polymeric formulations for retinal disorders. Their knowledge spans material science, pharmacy, and biomedicine, and they are highly motivated to drive advancements in therapeutic drug formulations and delivery.

Their work focuses on the intersection of neuroscience and nanomedicine, with a particular interest in developing nano-based drug delivery tools and therapies. Known for strong oral and written communication skills, they excel in collaborative, multidisciplinary environments, meeting tight deadlines, and delivering high-quality results.

Key Achievements and Experience:

• Awards and Scholarships:
  • Erasmus+ Scholarship for a joint Master’s program in Nanomedicine for Drug Delivery at Paris Descartes University.
  • Marie Sklodowska-Curie Scholarship to pursue doctoral research at the Center for Synaptic Neuroscience and Technology, Italian Institute of Technology.
• Collaborative Projects: Active contributor to two multinational research initiatives.
• Research Expertise:
  • Design and testing of polymeric and nano-based drug delivery systems.
  • Preclinical testing of therapeutic formulations for retinal disorders.
  • Strong grounding in material science, neuroscience, and biomedicine.

Their doctoral research exemplifies their ability to combine disciplines, integrating vision science and nanomedicine to address complex challenges. Beyond their technical skills, this researcher is approachable, adaptable, and collaborative, recognized for being an effective listener, open to new ideas, and focused on finding practical solutions.

Six years of academic experience in Europe have enriched their cross-cultural communication and interdisciplinary collaboration abilities. Passionate about translational research, they are driven by the potential of innovation and diverse perspectives to solve complex problems and create meaningful scientific impact.

Please reach out if you would like to be introduced to this rising star!

Accomplished chemical biologist with expertise in therapeutic RNA technology discovery and development. Led the creation of an RNAi-based platform, driving the advancement of multiple siRNA compounds targeting immuno-oncology and fibrosis, resulting in several clinical programs. Experienced in both leadership and collaborative roles within matrix environments, effectively managing and supporting cross-functional program teams.

Skills & Expertise

• Extensive experience in RNA therapeutic discovery and development.
• Proficiency in intellectual property portfolio management.
• Proven ability to lead programs from concept through design, development, clinical trials, and manufacturing.
• Strong laboratory expertise, including cell culture, compound design and optimization, study design, protocol development, in vitro research, data analysis, and scientific communication.
• Over 15 years of industry experience mentoring and managing direct reports, multidisciplinary teams, consultants, and external research organizations.
• Successful leadership in industry, academic, and grant-funded programs, guiding projects from discovery to clinical development.
• Expertise in regulatory submissions, ensuring timely preparation and filing of IND and IMPD documents.

Dedicated to advancing RNAi therapeutics, driving breakthrough discoveries, and cultivating high-performing teams to bring transformative treatments to patients and with a strong track record of innovation and leadership, this candidate is well-positioned to contribute significant value to any organization.

Results-driven marketing professional with expertise in both business and marketing, dedicated to driving growth in the biotech sector. Skilled in developing and implementing commercial strategies, with a talent for translating complex scientific concepts into clear, compelling content for healthcare professionals, patients, and other key stakeholders.

Experience: 

· Expertise in aligning marketing functions, including:

• Customer insights
• Campaign management
• Demand generation
• Digital marketing
• Market segmentation

· Skilled in identifying core business drivers and executing strategic initiatives from concept to implementation.

· Experienced in leveraging innovative marketing strategies to support growth and success in large-scale 

organizations.

· Proven ability to identify new market opportunities and drive strategic decision-making.

· Led initiatives to pinpoint high-potential therapeutic targets, contributing to pipeline development and market 

expansion.

· Managed multinational market research studies, enhancing regional capabilities and shaping targeted promotional strategies.

This dedicated professional is ready to develop a high-performing team and cultivate a culture of innovation and growth within your company. 

Visionary strategist, leader, and entrepreneur committed to harnessing technology to address critical human challenges, with a focus on biotechnology, health, and longevity. Passionate about transforming innovative concepts into real-world solutions through collaboration with top experts and industry pioneers. Open to leadership roles, strategic partnerships, and high-impact initiatives that drive meaningful change.

Seasoned executive with deep experience in startups, business strategy, and technology development. Skilled in navigating complex, interdisciplinary landscapes, seamlessly integrating biotechnology, engineering, software development, and entrepreneurship. Proficient in identifying and leveraging synergies between established technologies and emerging innovations to accelerate progress and sustainability.

Core Competencies:

• Leadership & Business Strategy: Executive leadership, startup growth, fundraising, corporate strategy, mergers and acquisitions, strategic partnerships, and board governance.
• Technology & Innovation: R&D, product development, AI, digital health, algorithm design, software engineering, and intellectual property strategy.
• Biotechnology & Life Sciences: 3D bioprinting, tissue engineering, regenerative medicine, biomimetics, medical devices, physiological data acquisition, and regulatory strategy.

An exceptional C-Suite thought leader based on the East Coast is seeking the opportunity to grow and scale an early-stage biotech company. With a wealth of experience spanning Biotech, Pharma, Venture Capital, and Strategic Consulting, this candidate has successfully led the development and advancement of multiple antiviral drugs, many of which have reached the market.

Expertise & Specialties:

• Subject Matter Expert (SME) in genomics, translational medicine, neuroscience, oncology, and biologics.
• Proven success in establishing new R&D sites and building discovery and early development pipelines.
• Experienced in leveraging both internal and external partnerships to drive the development of innovative medicines.
• Leadership of teams of up to 140 professionals across multiple geographical locations.
• Author of over 70 peer-reviewed publications covering recombinant gene expression in mammalian cells, matrix metalloproteinase biochemistry and disease function, heterotrimeric G protein signaling, as well as genomics and virology.

This leader brings a unique blend of scientific expertise, strategic vision, and operational excellence, making them the ideal candidate to drive the success of an emerging biotech venture.

A highly focused and motivated Senior Director with extensive experience across all stages of biotech and pharma is seeking a new challenge on the West Coast. With a Ph.D. in Biochemistry and over 20 years of expertise, this candidate is ready to contribute to your growing company.

Expertise & Specialties:

• Subject Matter Expert (SME) in viral vector development, stable cell line generation, and process development for cell therapy.
• Experienced in collaborating with external CMOs as an SME.
• Strategic and analytical thinker with a strong background in viral vector and product development from research through commercialization.
• Proven success in authoring IND sections for regulatory filings.
• Skilled in program and project management, ELISA, life sciences, protein expression, and molecular biology.
• Demonstrated success in product development, commercialization, and post-launch product support.
• Maintains a broad knowledge of principles and emerging technologies to drive innovation.
• Ensures seamless and timely transfer of new technologies and products for downstream development.

This candidate brings a wealth of experience and strategic leadership, making them an invaluable asset to any biotech or pharmaceutical team.

A dynamic and visionary Executive/C-Suite strategic leader based on the West Coast is seeking a new opportunity to drive meaningful impact. With a passion for improving lives, this thought leader brings a proven 20-year track record of success in the diagnostic and biotech start-up sectors.

Expertise & Specialties:

• Subject Matter Expert (SME): Oncology & Tumor Suppressors, Stem Cell Biology, Mitochondrial Physiology & Genetics
• A decade of experience in management recruiting and leading teams to develop advanced research and diagnostic products in the molecular genetic space.
• More than a dozen commercial launches for products in oncology diagnostics, infectious disease, epigenetics and mitochondrial biology
• Strong assay design and analytical skills as well as a deep understanding of assay development in qPCR and NGS technologies.
• Pioneer in the liquid biopsy diagnostic space with assays designed to capture and interrogate circulating tumor cells and circulating nucleic acids in blood, urine and other non-invasive sample types.
• Team lead for Research, Development, Clinical Affairs and Manufacturing departments across multiple organizations.

This leader is eager to leverage their expertise to drive innovation and make a lasting difference.

An accomplished and hands-on Research & Development Senior leader based on the East Coast is seeking the next step in their career. With a Ph.D. in Chemistry, a passion for scientific innovation, and an 18-year track record of success, this candidate is ready to elevate your team to new heights.

Expertise & Specialties:

• Led teams in synthesizing and purifying 130+ nt long modified nucleic acid sequences for in vitro, in vivo, and ex vivo gene editing research.
• Directed cross-functional teams for in-house synthesis and purification of large-scale batches, enabling successful NHP studies and drug candidate nominations.
• Developed strategic department initiatives to ensure the achievement of key scientific objectives across diverse teams.
• Contributed to drafting and reviewing regulatory documents for FDA discussions, contract proposals, RFPs for CMOs, and grant submissions for NIEHS, NSF, DoD, and Office of Naval Research SBIRs.
• Served as a Technical/Subject Matter Expert in meetings with domestic and international CMOs, supporting research projects and cGMP production campaigns.
• Focused on optimizing critical reactions to enhance yield, efficiency, throughput, and impurity control.
• Reviewed cGMP documents and batch records from CMOs for multi-kilo production campaigns of commercial API intermediates.
• Managed vendor relationships, procurement, and bulk material sourcing for large-scale synthesis and reagent testing.
• Recruited, trained, and mentored technical staff, new hires, and interns, fostering a high-performing team.
• Spearheaded the setup of multiple new laboratories, overseeing equipment procurement and research production readiness.

This candidate brings a unique blend of technical expertise and leadership, making them an invaluable asset to any R&D team.

A highly skilled Ph.D. and PMP with over 10 years of experience in both small biotech and large pharmaceutical companies, this strategic and innovative leader has held supervisory roles and made significant contributions to viral vaccine development. With 50 peer-reviewed research articles in high-impact journals and 3 patents, they have demonstrated expertise in advancing vaccine candidates through preclinical phases and supporting their transition into clinical development.

Key accomplishments include:

• Leading the creation of critical assays such as ELISA, microneutralization, western blot, and cell-based assays.
• Directing the isolation, characterization, and patenting of novel Zika-specific monoclonal antibodies.
• Spearheading the design and generation of recombinant viruses (Influenza, VSV, Rinderpest/PPR) and viral vectors (VSV, MVA) as vaccine candidates.
• Providing expert input into study plans, technical documents, and regulatory submissions (IND/NDA, IBs, IMPD, BLA), showcasing a deep expertise in vaccine development.

Core skills and competencies:

• Project management, performance excellence, and team leadership
• Expertise in cross-functional and matrix environments, collaborating with CROs and global partners
• Laboratory management and environmental compliance
• Virology, immunology, molecular biology, and reverse genetics
• Advancing vaccine candidates through preclinical evaluation and into clinical development
• Assay development, biomarker analysis, and translational sciences
• Immunogenicity studies, in vivo efficacy assessments, and proof-of-concept studies